How to interpret immunohistochemistry results for breast cancer
Breast cancer immunohistochemical results can be interpreted through ER, PR, Ki67, and Her-2. The specific analysis is as follows:
1. ER
Estrogen receptor, a type of protein molecule. After patients receive endocrine therapy, this marker usually shows significant changes. A positive result indicates that this treatment approach is effective.
2. PR
Progesterone receptor, a protein located within target cells that mediates the effects of progesterone. Similar to ER, a positive result suggests a better prognosis.
3. Ki67
A marker antigen associated with proliferating cells and essential for cell division. A positive result typically indicates a poor prognosis.
4. Her-2
Human epidermal growth factor receptor 2, also one of the genes associated with breast cancer. A positive result often indicates a higher likelihood of metastasis and a poorer prognosis.
Patients are advised to proceed with further treatment based on their individual test results.